Predictions
Biogen Inc.
Start price
Target price
Perf. (%)
€205.20
12.05.24
12.05.24
€207.00
12.05.25
12.05.25
3.85%
06.06.24
06.06.24
Good rating
Standard Investments for future growth
Innovative
Differentiated customer and product portfolio
Biogen Inc.
Start price
Target price
Perf. (%)
€205.20
12.05.24
12.05.24
€207.00
12.05.25
12.05.25
3.85%
06.06.24
06.06.24
Good rating
Standard Investments for future growth
Innovative
Differentiated customer and product portfolio
Biogen Inc.
Start price
Target price
Perf. (%)
€205.20
12.05.24
12.05.24
€207.00
12.05.25
12.05.25
3.85%
06.06.24
06.06.24
Good rating
Standard Investments for future growth
Innovative
Differentiated customer and product portfolio
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€307.95
30.05.23
30.05.23
€356.18
30.05.24
30.05.24
33.25%
31.05.24
31.05.24
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€307.95
30.05.23
30.05.23
€356.18
30.05.24
30.05.24
33.25%
31.05.24
31.05.24
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€307.95
30.05.23
30.05.23
€356.18
30.05.24
30.05.24
33.25%
31.05.24
31.05.24
Insmed Inc.
Start price
Target price
Perf. (%)
€20.40
28.05.24
28.05.24
€38.00
30.06.26
30.06.26
109.80%
28.05.24
28.05.24
Could be very worthwhile Investment >20% year
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€397.00
24.05.23
24.05.23
€464.75
24.05.24
24.05.24
88.34%
25.05.24
25.05.24
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€397.00
24.05.23
24.05.23
€462.89
24.05.24
24.05.24
88.34%
25.05.24
25.05.24
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€403.60
14.05.23
14.05.23
€700.00
14.05.24
14.05.24
76.01%
15.05.24
15.05.24
Could be worthwhile Investment >10% per year
Biogen Inc.
Start price
Target price
Perf. (%)
€194.35
27.04.24
27.04.24
€200.00
27.04.25
27.04.25
5.58%
12.05.24
12.05.24
Good rating
Standard Investments for future growth
Innovative
Differentiated customer and product portfolio
Biogen Inc.
Start price
Target price
Perf. (%)
€194.35
27.04.24
27.04.24
€200.00
27.04.25
27.04.25
5.58%
12.05.24
12.05.24
Good rating
Standard Investments for future growth
Innovative
Differentiated customer and product portfolio
Biogen Inc.
Start price
Target price
Perf. (%)
€194.35
27.04.24
27.04.24
€200.00
27.04.25
27.04.25
5.58%
12.05.24
12.05.24
Good rating
Standard Investments for future growth
Innovative
Differentiated customer and product portfolio
ImmunityBio Inc.
Start price
Target price
Perf. (%)
€2.30
29.10.23
29.10.23
€4.00
30.06.26
30.06.26
247.39%
29.04.24
29.04.24
Could be very worthwhile Investment >20% year
Inotiv Inc.
Start price
Target price
Perf. (%)
€5.50
13.04.24
13.04.24
€4.00
13.04.25
13.04.25
-32.36%
27.04.24
27.04.24
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Little Investments for future growth
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€56.40
20.04.23
20.04.23
€60.11
20.04.24
20.04.24
22.34%
21.04.24
21.04.24
Alpine Immune Sciences Inc
Start price
Target price
Perf. (%)
€11.50
22.07.23
22.07.23
€15.00
31.08.26
31.08.26
430.43%
12.04.24
12.04.24
Could be very worthwhile Investment >20% year
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€103.40
11.04.23
11.04.23
€113.61
11.04.24
11.04.24
13.73%
12.04.24
12.04.24
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€103.40
11.04.23
11.04.23
€113.61
11.04.24
11.04.24
13.73%
12.04.24
12.04.24
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€34.60
03.04.23
03.04.23
€56.02
03.04.24
03.04.24
87.86%
04.04.24
04.04.24
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€32.60
31.03.23
31.03.23
€45.16
31.03.24
31.03.24
110.12%
01.04.24
01.04.24